Advanced search×

Estrogen, aging and the cardiovascular system

Future Cardiol 5(1):93-103 (2009) PMID 19371207

Estrogen is a powerful hormone with pleiotropic effects. Estrogens have potent antioxidant effects and are able to reduce inflammation, induce vasorelaxation and alter gene expression in both the vasculature and the heart. Estrogen treatment of cultured cardiac myocytes and endothelial cells rapidly activates NFkappaB, induces heat-shock protein (HSP)-72, a potent intracellular protective protein, and protects cells from simulated ischemia. In in vivo models, estrogens protect against ischemia and trauma/hemorrhage. Estrogens may decrease the expression of soluble epoxide hydrolase, which has deleterious effects on the cardiovascular system through metabolism of epoxyeicosatrienoic acids. Natural (endogenous) estrogens in premenopausal women appear to protect against cardiovascular disease and yet controlled clinical trials have not indicated a benefit from estrogen replacement postmenopause. Much remains to be understood in regards to the many properties of this powerful hormone and how changes in this hormone interact with aging-associated changes. The unexpected negative results of trials of estrogen replacement postmenopause probably arise from our lack of understanding of the many effects of this hormone.

DOI: 10.2217/14796678.5.1.93
Version: za2963e q8za5 q8zbd q8zc5 q8zdd q8zed q8zfc q8zgd

Similar articles you may find interesting…

  1. Assessment of 126,913 inguinal hernia repairs in the Emilia-Romagna region of Italy: analysis of 10 years.

    Hernia (2013) PMID 23677326

    126,913 inguinal hernioplasty procedures were performed. The annual rate was on average 34 per 10,000 inhabitants. An increase of the case mix complexity and relevant changes in procedure technique were recorded. From multivariate analysis, the following independent factors related to a hospitalizat...
  2. Adult stem cells for chronic lung diseases.

    Respirology (2013) PMID 23648014

    We discuss the repair response of bone marrow derived mesenchymal stem cells (B-MSCs) after lung injury and how their function is affected by aging. Our own work has demonstrated a protective role of B-MSCs in several animal models of acute and chronic lung injury. We recently demonstrated the assoc...
  3. Chain-Shattering Polymeric Therapeutics with On-Demand Drug-Release Capability.

    Angew Chem Int Ed Engl (2013) PMID 23650111

    Trigger happy: Trigger-responsive chain-shattering polymeric therapeutics (CSPTs) were prepared by condensation polymerization of a UV- or hydrogen peroxide-responsive domain and a drug as co-monomers. Drug release can be started and stopped by starting and stopping the trigger treat...